Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CTVA
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.04 1.51 1.56
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 594.24 2.47 -0.36
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.57 35.36 35.56
Cash -20.56 3.09 3.89
Capex 18.71 -0.21 -0.26
Free Cash Flow -34.04 -3.94 5.97
Revenue 21.80 6.41 5.27
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 12.31 0.41 0.36
Operating Margin 403.80 0.17 0.03
ROA 63.22 < 0.005 < 0.005
ROE 67.42 0.02 -0.01
ROIC 523.32 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CTVA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CTVA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CTVA is permitted for members.